What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Arch Venture Fund VIII Overage, LP: large open-market buy of NMRA
$5M open-market purchase by Arch Venture Fund VIII Overage, LP, 10% Owner at Neumora Therapeutics,Inc., filed October 29, 2025. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View NMRA
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyNMRA
$1.74-0.57% today
Arch Venture Fund VIII Overage, LP · 10% Owner at Neumora Therapeutics,Inc.
$5M
Arch Venture Fund VIII Overage, LP bought $5M of NMRA (Neumora Therapeutics,Inc.).
Insider purchase
Transaction details
Arch Venture Fund VIII Overage, LP, a 10% beneficial owner, reported a $5M open-market purchase equal to 1.5% of NMRA's market cap.
Arch Venture Fund VIII Overage, LP (10% Owner) bought 1,915,700 shares of NMRA, Neumora Therapeutics,Inc., Healthcare ($342.8M market cap), at $2.61 per share on October 27, 2025 for a total of $5M (1.5% of the market cap).
Arch Venture Fund VIII Overage, LP
10% Owner
Purchase value$5M
Shares purchased1,915,700
Price per share$2.61 per share
- % of market cap
- 1.5%
- Trade date
- October 27, 2025
- Filed
- October 29, 2025
- Filing delay
- 2 days
Permalink https://bluecollarpicks.com/insider-trading/NMRA/buy/68249
Market context
NMRA market snapshot
Current price$1.74
1-day change-0.57%
Market cap$342.8M
SectorHealthcare
Next earningsAugust 3, 2026
$1.74
Current price$1.74
Analyst target$8.91 (+381.5%)
Last enriched June 5, 2026 at 8:25 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Grant Director | $0 | ||
Sell Officer | $21.9K | ||
Sell President | $21.1K | ||
Sell Director | $34.5K | ||
| $5.1K | |||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant President | $0 | ||
Grant Officer | $0 | ||
Grant Director | $0 | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy Director | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
Cluster Buy 10% Owner | $5M | ||
| This filing | Cluster Buy 10% Owner | $5M | |
Sell Director | $23.5K | ||
Sell President | $13.5K | ||
Sell Officer | $9.4K | ||
Sell Officer | $3.4K | ||
Sell Officer | $14.3K | ||
$21.9K
Sell Officer
$21.1K
Sell President
$34.5K
Sell Director
$5.1K
$0
Grant Officer
Grant Officer
$0
Grant President
Grant Officer
$0
Grant Director
Cluster Buy 10% Owner
$5M
Cluster Buy 10% Owner
Cluster Buy 10% Owner
$5M
Cluster Buy 10% Owner
$5M
Cluster Buy 10% Owner
Cluster Buy 10% Owner
$5M
Cluster Buy 10% Owner
$5M
Cluster Buy Director
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
Cluster Buy 10% Owner
$23.5K
Sell Director
$13.5K
Sell President
$9.4K
Sell Officer
$3.4K
Sell Officer
$14.3K
Sell Officer
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.